|Scoping workshop:||18 March 2013|
|Consultation on draft scope with stakeholders:||10 April - 8 May 2013|
|Consultation on draft guideline with stakeholders:||28 January 2015 - 11 March 2015|
|Centre for clinical practice lead:||Martin Allaby|
|Communications manager:||Elizabeth Adelanwa|
|Guidelines commissioning manager:||
|Guidelines coordinator:||Margaret Ghlaimi|
|Patient involvement lead:||Emma Chambers|
|Implementation lead:||Denise Woods|
|Guidelines Development Group:||The Guideline Development Group (GDG) oversees the development process.|
|11 August 2015||
The NICE guideline on asthma diagnosis and monitoring will be delayed until later this year. This is to allow additional time to work with commissioners and healthcare professionals in asthma care to make sure the recommendations can be introduced effectively and efficiently.
The guideline proposes some radical and innovative changes with considerable benefits for patients and the NHS as a whole, but we accept this will be challenging to introduce. Smooth implementation of this guideline will help millions of adults, children and young people get the right diagnosis and better control their asthma symptoms as well as offer considerable savings to the NHS and beyond.
The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4 weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG. The Health Economic plan, review questions and search strategies will be available on the website 5 weeks prior to consultation commencing.
|7 June 2013||
The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table. The Guideline Development Group (GDG) oversees the development process.
Consultation on the draft scope is complete and the scope is being modified in the light of comments received. When completed it will be posted on the website. It will define what aspects of care the guideline will cover and to whom it will apply.
The National Collaborating Centre and the Institute are in the process of agreeing details of the workplan including how the development will progress, the membership of the Guideline Development Group and timescales.
|10 April - 8 May 2013||
The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.
The NCC is currently looking to recruit members for the Guideline Development Group (GDG).
|7 September 2012||The remit was received from the Department of Health and the Welsh Government in August 2012.|